Australian Dairy Farms has completed its deal to acquire local organic infant formula maker Flahey’s Nutritionals.

And, in an announcement to the Australian Securities Exchange (ASX), it revealed it will in future be known as Australian Dairy Nutritionals to reflect the move into a new area. 

Go deeper with GlobalData

Data Insights

The gold standard of business intelligence.

Find out more

Related Company Profiles

View all

The deal was first announced back in August with a proposed purchase price of AUD1.5m (US$1.1m).

Australian Dairy Farms said the deal was a key step for it in entering the dairy nutritionals and infant/toddler formula market. 

While Flahey’s Future baby formula is new to the Australian market, it is being slowly launched across the country through pharmacies such as Chemist Warehouse, Chemist Outlet, Blooms the Chemist, Priceline, Soul Pattinson and Pharmacist Advice. 

Flahey’s Nutritionals has been developing a range of premium infant formula products.

How well do you really know your competitors?

Access the most comprehensive Company Profiles on the market, powered by GlobalData. Save hours of research. Gain competitive edge.

Company Profile – free sample

Thank you!

Your download email will arrive shortly

Not ready to buy yet? Download a free sample

We are confident about the unique quality of our Company Profiles. However, we want you to make the most beneficial decision for your business, so we offer a free sample that you can download by submitting the below form

By GlobalData
Visit our Privacy Policy for more information about our services, how we may use, process and share your personal data, including information of your rights in respect of your personal data and how you can unsubscribe from future marketing communications. Our services are intended for corporate subscribers and you warrant that the email address submitted is your corporate email address.

When the deal was first announced, Peter Skene, the chief executive of Australian Dairy Farms, said the market for organic infant formula in Australia and New Zealand is expected to more than double between 2017 and 2023, from AUD230m in 2017 to AUD546m by 2023.

He said at the time the company’s strategy was to transition “from a conventional basic producer of low-value products, to a premium differentiated branded business”.